XRTX XORTX Therapeutics Inc Total Asset Value of Company
The market price visualization for XORTX Therapeutics Inc. (XRTX) demonstrates total assets, which currently stand at 4.46, as the company maintains a lean staff of leading nephrologists. The business relies on the development of treatments for polycystic kidney disease, where success depends on inhibitor testing and trial recruitment rates. The strategy is based on developing lifelong therapies for chronic pathologies, ensuring the multi-year commercial exploitation of patents.
Analytical breakdowns and data insights for company XORTX (XRTX)
- stock quotes and analyst forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio XORTX Therapeutics Inc.|XRTX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio XORTX Corp|XRTX - Company Aggregate Debts|Debts to Book Capitalization XORTX Corp|XRTX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings XORTX Therapeutics|Interim Coverage Ratio xortx.com
- net income and valuation multiples indicators:
Fundamental valuation:XORTX Therapeutics Inc.
Investors assess business scalability through resource volume, where this indicator, reverse-calculated from return on assets (ROA), determines the total value of assets and liabilities. Amid geopolitical sanctions and logistics disruptions, XORTX Therapeutics Inc. may exhibit a stagnant base; therefore, the trend in total assets becomes a critical marker of the company's ability to sustain clinical trials despite external barriers.
Key competitors
Total Business Assets ARGX|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|SVRA: Cumulative Company Assets|RIGL (Rigel Corp) - Total Business Assets|AnaptysBio, Inc. (ANAB) - Aggregate Company Assets|Company Assets astriatx.com (ATXS)|Aggregate Company Assets enGene|RAPT: Aggregate Asset Value|Cumulative Company Assets JBIO (Aerovate Therapeutics Inc)|Aggregate Business Assets ACRS|Kyverna Therapeutics - Cumulative Company Assets|TLSA: Total Business Assets|CABA: Cumulative Company Assets|Aggregate Asset Value VTYX (Ventyx Biosciences Inc.)|THTX (Theratechnologies Inc) - Cumulative Company Assets|AVTX: Aggregate Business Assets|ELDN (Eledon Pharmaceuticals) - Company Total Assets|AGEN: Aggregate Asset Value|Company Total Assets CLYM|ZURA - Company Assets|Aggregate Company Assets aTyr ATYR|Aggregate Asset Value ADAG|Ikena Oncology, Inc. - Company Total Assets|STTK - Company Total Assets|equilliumbio.com (EQ) - Aggregate Company Assets|Total Asset Value of Company CNTB (Connect Biopharma Holdings Limited)|IMUX (Immunic Therapeutics) - Company Total Assets|Company Assets Atara Biotherapeutics Inc ATRA|Cumulative Company Assets IFRX (InflaRx N.V.)|Company Total Assets x4pharma.com (XFOR)|Adicet Bio, Inc. - Cumulative Company Assets|Aggregate Business Assets CELU (Celularity Inc)|INmune Bio Corp - Company Total Assets|Company Total Asset Base Barinthus Biotherapeutics Corp BRNS|KZR: Company Total Assets|Cumulative Company Assets sabbiotherapeutics.com|Aggregate Company Assets Akari Therapeutics Plc|Enlivex Therapeutics, Ltd. (ENLV) - Company Total Asset Base|Cumulative Company Assets QTTB (Q32 Bio Inc.)|GOVX (GeoVax Corp) - Aggregate Asset Value|Company Total Assets EDSA (Edesa Biotech, Inc.)|Company Total Asset Base ibioinc.com (IBIO)|CARM - Aggregate Company Assets|XTLB (XTL Biopharmaceuticals Ltd) - Total Business Assets|BOLT: Company Total Assets|Cumulative Company Assets HCW Biologics|Cumulative Company Assets APVO|AIM ImmunoTech, Inc. (AIM) - Company Total Asset Base|Cumulative Company Assets ADTX (Aditxt)|GRI Bio Inc - Total Business Assets|Aggregate Company Assets ReShape Lifesciences HIND|Aggregate Asset Value REVB|INDP: Cumulative Company Assets|scinai.com - Aggregate Business Assets|CALI (calcimedica.com) - Cumulative Company Assets|Total Business Assets AFMD|Aggregate Company Assets Allakos Inc|HOOKIPA - Total Asset Value of Company|Company Total Assets IGMS|ITOS (iteostherapeutics.com) - Aggregate Asset Value|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|THRD - Aggregate Company Assets